These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 35705772)

  • 1. Recent advances of the biological and biomedical applications of CRISPR/Cas systems.
    Wang Y; Huang C; Zhao W
    Mol Biol Rep; 2022 Jul; 49(7):7087-7100. PubMed ID: 35705772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid Control of Genome Editing in Human Cells by Chemical-Inducible CRISPR-Cas Systems.
    Liu KI; Ramli MNB; Sutrisnoh NB; Tan MH
    Methods Mol Biol; 2018; 1772():267-288. PubMed ID: 29754234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in CRISPR-Cas-mediated genome editing system in plants].
    Wang C; Wang K
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1712-1722. PubMed ID: 29082719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Industrial Biotechnology Using CRISPR-Cas Systems.
    Donohoue PD; Barrangou R; May AP
    Trends Biotechnol; 2018 Feb; 36(2):134-146. PubMed ID: 28778606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of the CRISPR-Cas9 system in cancer biology.
    Sánchez-Rivera FJ; Jacks T
    Nat Rev Cancer; 2015 Jul; 15(7):387-95. PubMed ID: 26040603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Based Technologies: Impact of RNA-Targeting Systems.
    Terns MP
    Mol Cell; 2018 Nov; 72(3):404-412. PubMed ID: 30388409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient genome editing in zebrafish using a CRISPR-Cas system.
    Hwang WY; Fu Y; Reyon D; Maeder ML; Tsai SQ; Sander JD; Peterson RT; Yeh JR; Joung JK
    Nat Biotechnol; 2013 Mar; 31(3):227-9. PubMed ID: 23360964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prime editing in plants and mammalian cells: Mechanism, achievements, limitations, and future prospects.
    Hillary VE; Ceasar SA
    Bioessays; 2022 Sep; 44(9):e2200032. PubMed ID: 35750651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas genome editing to optimize pharmacologically active plant natural products.
    Dey A
    Pharmacol Res; 2021 Feb; 164():105359. PubMed ID: 33285226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
    Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
    BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPER/Cas in Plant Natural Product Research: Therapeutics as Anticancer and other Drug Candidates and Recent Patents.
    Dey A; Nandy S
    Recent Pat Anticancer Drug Discov; 2021; 16(4):460-468. PubMed ID: 34911411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CRISPR/Cas: a novel way of RNA-guided genome editing].
    Li J; Zhang Y; Chen KL; Shan QW; Wang YP; Liang Z; Gao CX
    Yi Chuan; 2013 Nov; 35(11):1265-73. PubMed ID: 24579309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A short overview of CRISPR-Cas technology and its application in viral disease control.
    Ghorbani A; Hadifar S; Salari R; Izadpanah K; Burmistrz M; Afsharifar A; Eskandari MH; Niazi A; Denes CE; Neely GG
    Transgenic Res; 2021 Jun; 30(3):221-238. PubMed ID: 33830423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cas9, Cpf1 and C2c1/2/3-What's next?
    Nakade S; Yamamoto T; Sakuma T
    Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
    Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
    Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology.
    Ishino Y; Krupovic M; Forterre P
    J Bacteriol; 2018 Apr; 200(7):. PubMed ID: 29358495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The discovery and development of the CRISPR system in applications in genome manipulation.
    Lau V; Davie JR
    Biochem Cell Biol; 2017 Apr; 95(2):203-210. PubMed ID: 28103055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR Mediated Genome Engineering and its Application in Industry.
    Kaboli S; Babazada H
    Curr Issues Mol Biol; 2018; 26():81-92. PubMed ID: 28879858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of CRISPR/Cas System to Bacterial Metabolic Engineering.
    Cho S; Shin J; Cho BK
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29621180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Progress and Future Prospect of CRISPR/Cas-Derived Transcription Activation (CRISPRa) System in Plants.
    Ding X; Yu L; Chen L; Li Y; Zhang J; Sheng H; Ren Z; Li Y; Yu X; Jin S; Cao J
    Cells; 2022 Sep; 11(19):. PubMed ID: 36231007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.